Dr. Nikhil Agrawal has been invited as faculty at national and international conferences, sharing his expertise in GI-HPB surgical oncology.
A multidisciplinary panel discussion on the management of locally advanced hepatocellular carcinoma, covering surgical strategies, systemic therapy, and emerging treatment approaches.
A multidisciplinary panel discussion on the management of locally advanced pancreatic cancer and colorectal liver metastasis, covering surgical strategies, chemotherapy protocols, and emerging treatment approaches.
A debate on the optimal surgical approach for resectable pancreatic cancer, presenting the case for upfront surgery over neoadjuvant therapy.
A critical evaluation of surgical resection versus immunotherapy in deficient mismatch repair colon cancer.
01 · GE Junction
A detailed demonstration of robotic Ivor Lewis esophagectomy for Siewert type II GE junction cancers, presented at the Indian Association of Surgical Gastroenterology (IASG) Mid-Term Conference in Patna.
02 · Colorectal Liver Metastasis
A multidisciplinary panel discussion on the management of colorectal liver metastases, covering surgical resection, ablation, systemic therapy, and multidisciplinary decision-making.
Across a 4-hour live discussion, 11 international experts from 7 countries shared their perspectives on screening, multidisciplinary care, surgical advances, and emerging targeted therapies shaping hepatobiliary oncology.
A focused discussion on the surgical management of difficult colorectal liver metastases — covering patient selection, advanced resection techniques, and pragmatic strategies for overcoming resource constraints in developing countries, presented at the NASG Conference in Nepal.
A comprehensive discussion on aggressive surgical approaches for biliary malignancies, presented at the IHPBA Conference in Jaipur.
A live operative demonstration of robotic right hemicolectomy, highlighting complete mesocolic excision, central vascular ligation, D3 lymphadenectomy, and intracorporeal anastomosis.
Strategies for patient selection and surgical optimization for hepatocellular carcinoma in settings with limited resources.
A multidisciplinary panel discussion on the challenges of managing gastroesophageal junction cancers, which traverse both the thoracic and abdominal cavities.
01 · Robotic
A demonstration of robotic-assisted liver resection for hepatic tumours and metastases, highlighting advanced minimally invasive techniques in HPB surgery.
02 · Incidental Gallbladder Cancer
A practical discussion on the management of incidental gallbladder cancer, from risk stratification to completion radical cholecystectomy.
A detailed walkthrough of the robotic gastrectomy technique with emphasis on achieving a thorough D2 lymph node dissection, presented at the FALS Robotic Conference.
Oncology Conundrum brings together oncologists for meaningful discussions and sharing experiences. Contributed our experience on the robotic Whipple procedure—a minimally invasive approach to one of the most demanding surgeries in GI oncology, used to treat pancreatic and periampullary cancers. The idea? Less pain, faster recovery, and better outcomes.
Focus on improving outcomes for BTC patients. Biliary tract cancers are among the most complex and technically demanding malignancies in gastrointestinal oncology.
In borderline resectable pancreatic cancer, neoadjuvant chemotherapy followed by surgery has become the standard of care. Whether the same strategy should be applied to resectable pancreatic cancer remains fiercely debated—a position weighed on the debate floor at the National Conference of the Indian Chapter of IHPBA in Kolkata.
An invited presentation on surgical approaches in gastrointestinal and hepatopancreatobiliary oncology, shared with a national audience of surgical and medical oncologists at the Max Cancer Congress in Mumbai.
Joined a multidisciplinary panel on managing resectable gastric cancers and delivered a talk comparing laparoscopic and robotic surgical approaches at this summit on multidisciplinary pathways in GI oncology.
Spoke in the abdomen session of this surgical conference, covering the rationale, technique, and outcomes of robotic colectomy.
Delivered a talk on the role of surgery in gastric cancer management and joined a panel discussion on the current second-line treatment landscape for advanced HER2-positive gastric and gastroesophageal junction cancers.
Discussed the evaluation and management of a pancreatic head mass presenting with jaundice — differentiating benign from malignant disease, staging workup, and planning resection.
Two invited talks at the national IASG conference — selecting the appropriate liver resection for hilar cholangiocarcinoma in the malignant liver session, and optimal management of oligometastatic gastric cancer in the upper GI session.
Two talks at this GI and HPB oncology update — reviewing the principles of radical cholecystectomy and discussing the surgical approach to gastric cancer.
An invited talk in the GI & Hepatobiliary session of this multidisciplinary oncology meeting built around the theme of closing the care gap, discussing how neoadjuvant treatment sequences can be tailored for rectal cancer patients.
Moderated a panel at this two-day scientific meet on HPB malignancies, steering the discussion on whether colorectal liver metastasis management should move towards a uniform treatment approach.
Argued the case for upfront surgery in resectable pancreatic cancer at this advances-in-cancer-care conference, weighing perioperative strategies against the growing push for neoadjuvant therapy.
Moderated a multidisciplinary panel dissecting contemporary rectal cancer trials — including preoperative treatment of locally advanced disease and organ-preservation strategies with radiation dose escalation.
Presented in the esophagus session of this national surgical gastroenterology conference, critically examining the value and morbidity of supra-carinal nodal dissection in squamous cell carcinoma of the esophagus.
Joined an expert panel at the colorectal symposium during the Indian Cancer Congress, sharing approaches to critical steps of low anterior resection and strategies to reduce anastomotic leaks.
Presented an operative video of a minimally invasive choledochal cyst excision at this IHPBA India workshop and certificate course for HPB trainees.
Joined a multidisciplinary panel at this nuclear medicine conference, debating the real-world promise of FAP inhibitors imaging and therapy in oncology practice.
Contributed to an expert panel in the post-operative complications session of this joint meeting of the International Association of Pancreatology and the Indian Pancreas Club, sharing experience in recognising and managing post-Whipple complications.
Participated as a panelist working through staged rectal cancer cases and scenarios, discussing imaging interpretation and its impact on treatment selection.
Moderated the post-session discussion at this update meeting on colon cancer and surgery for ulcerative colitis, drawing together key teaching points from the faculty talks.
Moderated a panel discussion on the management of middle-third esophageal cancers, exploring neoadjuvant chemoradiotherapy pathways and treatment beyond NACTRT.
Delivered a talk presenting the surgeon’s perspective across the HCC treatment spectrum, from resection to transplantation, and joined a case-based panel giving an overview of hepatocellular carcinoma management.
Joined a case-based discussion on pseudomyxoma peritonei at this joint INDEPSO–ISPSM meeting endorsed by PSOGI, covering cytoreductive surgery, HIPEC, and patient selection.
Moderated a case-based multidisciplinary discussion on locally advanced gastroesophageal junction cancer and delivered a talk on the role of liver resection in colorectal liver metastasis at this mid-term CME.
Participated in a multidisciplinary, case-based panel at this national conference focused on real-world strategies that maximize clinical outcomes in colorectal liver metastasis.
Spoke in the Esophagus Controversies session, examining whether a complete response after neoadjuvant chemoradiotherapy justifies active surveillance over surgery in esophageal cancer.
Presented in the colorectal cancer session, appraising the evidence on cytoreductive surgery with HIPEC and its real impact on outcomes.
Moderated a session on the role of MRI in rectal cancer — staging accuracy, circumferential resection margin assessment, and how imaging shapes surgical planning.
Demonstrated the technique of laparoscopic hepaticojejunostomy for benign biliary strictures at the IHPBA India national meet.
Joined an international panel in the pancreatic diseases session of the CME program at the XXIX IASG national conference, discussing management strategies for borderline resectable pancreatic cancer.
Discussed the role of bariatric and metabolic surgery in achieving diabetes remission, presenting the surgical viewpoint to a predominantly metabolic and endocrine audience.
A session on the diagnostic and therapeutic dilemma of ileocaecal masses, covering how to distinguish inflammatory from neoplastic pathology, the role of imaging and colonoscopy, and operative decision-making.
A talk in the liver cancer session of this symposium on hepatobiliary and pancreatic cancer management, covering the preoperative workup before liver resection — patient selection, liver function assessment, and imaging to plan a safe oncological resection.
A talk in the pancreatic cancer session, covering the preoperative evaluation and staging of pancreatic cancer — imaging, staging laparoscopy, and assessment of resectability to guide treatment planning.
A session in the Bursary Programme under the Research and Publications track, covering how to effectively search the medical literature and use PubMed to support evidence-based surgical practice and research.
Liver cancer and liver diseases are a growing menace. Scientists are at the forefront and backbone of everything we do. We had an interesting and informative session on the occasion of World Liver Day.
An invited CME faculty session at the IASG Mid-Term Conference 2024, sharing experience and contemporary evidence in GI and HPB surgical oncology with postgraduate trainees and practising surgeons.
An invited panelist at IASGCON 2025, contributing to a multidisciplinary panel discussion on the management of colorectal liver metastases, covering surgical resection strategies, systemic therapy sequencing, and multidisciplinary decision-making.